Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson’s Disease (PD)

By Tuite Paul  

Brain Sciences, Vol. 7, Iss. 6, 2017-06 ,pp. : 68-68

MDPI

Access to resources Recommend Favorite

Influence of Transgenic Metallothionein-1 on Gliosis, CA1 Neuronal Loss, and Brain Metal Levels of the Tg2576 Mouse Model of Alzheimer’s Disease

By Comes Gemma   Manso Yasmina   Escrig Anna   Fernandez-Gayol Olaya   Sanchis Paula   Molinero Amalia   Giralt Mercedes   Carrasco Javier   Hidalgo Juan  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 251-251

MDPI

Access to resources Recommend Favorite

Candesartan ameliorates brain inflammation associated with Alzheimer's disease

By  

CNS: NEUROSCIENCE AND THERAPEUTICS, Vol. 24, Iss. 3, 2018-03 ,pp. : 231-242

John Wiley & Sons Inc

Access to resources Recommend Favorite

Magnetic resonance imaging as a tool to image neuroinflammation in a rat model of Parkinson's disease – phagocyte influx to the brain is promoted by bilberry‐enriched diet

By  

EUROPEAN JOURNAL OF NEUROSCIENCE, Vol. 42, Iss. 10, 2015-11 ,pp. : 2761-2771

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effective network of deep brain stimulation of subthalamic nucleus with bimodal positron emission tomography/functional magnetic resonance imaging in Parkinson's disease

By  

CNS: NEUROSCIENCE AND THERAPEUTICS, Vol. 24, Iss. 2, 2018-02 ,pp. : 135-143

John Wiley & Sons Inc

Access to resources Recommend Favorite